Criteria for surrogate end points
暂无分享,去创建一个
Zhi Geng | Jinzhu Jia | Z. Geng | Jinzhu Jia | Hua Chen | Hua Chen
[1] A. Dawid. Influence Diagrams for Causal Modelling and Inference , 2002 .
[2] J. Angrist,et al. Identification and Estimation of Local Average Treatment Effects , 1995 .
[3] D. DeMets,et al. Surrogate End Points in Clinical Trials: Are We Being Misled? , 1996, Annals of Internal Medicine.
[4] R. Prentice. Surrogate endpoints in clinical trials: definition and operational criteria. , 1989, Statistics in medicine.
[5] J. Pearl. Causality: Models, Reasoning and Inference , 2000 .
[6] S. Lauritzen. Discussion on Causality , 2004 .
[7] D. Rubin,et al. Principal Stratification in Causal Inference , 2002, Biometrics.
[8] P. Spirtes,et al. Causation, prediction, and search , 1993 .
[9] Nanny Wermuth,et al. A general condition for avoiding effect reversal after marginalization , 2003 .
[10] D. Rubin. Estimating causal effects of treatments in randomized and nonrandomized studies. , 1974 .
[11] E. H. Simpson,et al. The Interpretation of Interaction in Contingency Tables , 1951 .
[12] James Durbin,et al. Errors in variables , 1954 .
[13] G. Yule. NOTES ON THE THEORY OF ASSOCIATION OF ATTRIBUTES IN STATISTICS , 1903 .
[14] B. Kramer,et al. A perfect correlate does not a surrogate make , 2003, BMC medical research methodology.
[15] Steffen L. Lauritzen,et al. Causal Inference from Graphical Models , 2001 .